Clinical trial

Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer

NCT06518226

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-03-28

PhaseNA

Study timeline

Study start (actual)2024-03-28Date precision: day

Registry last updated2024-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Prostate Adenocarcinomaunresolved

Localized Prostate Carcinomaunresolved

Interventions

Ultrahypofractionated MRgRT in 2 fractionsRADIATION

Standard of care: MRgRT in 5 fractionsRADIATION

Sponsors & collaborators

UMC Utrechtlead sponsor

Mapped research locations

UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06518226 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.